The Effect of Supervised Exercise Therapy on Physical Activity and Ambulatory Activities in Patients with Intermittent Claudication

被引:20
作者
Fokkenrood, H. J. P. [1 ,2 ]
Lauret, G. J. [1 ,2 ]
Verhofstad, N. [1 ]
Bendermacher, B. L. W. [3 ]
Scheltinga, M. R. M. [4 ,5 ]
Teijink, J. A. W. [1 ,2 ]
机构
[1] Catharina Hosp, Dept Vasc Surg, NL-5602 ZA Eindhoven, Netherlands
[2] Maastricht Univ, CAPHRI Res Sch, NL-6200 MD Maastricht, Netherlands
[3] Canisius Ziekenhuis, Dept Vasc Surg, NL-6500 GS Nijmegen, Netherlands
[4] Maxima Med Ctr, Dept Vasc Surg, NL-5500 MB Veldhoven, Netherlands
[5] Maastricht Univ, CARIM Res Sch, NL-6200 MD Maastricht, Netherlands
关键词
Activity monitor; Peripheral arterial disease; Physical activity; Supervised exercise; ALL-CAUSE MORTALITY; PERIPHERAL ARTERY-DISEASE; SF-36 HEALTH SURVEY; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; SYSTEM ACCURACY; ADULTS; RISK; INTERVENTION; VALIDATION;
D O I
10.1016/j.ejvs.2014.11.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective/Background: Intermittent claudication (IC) is associated with a reduction in physical activity (PA) and a more rapid functional decline leading to a higher mortality rate compared with healthy individuals. Supervised exercise therapy (SET) is known to increase the walking capacity of patients with IC. However, it is unclear whether SET increases PA. The aim of this study was to investigate the effect of SET on PA levels and ambulatory activities in patients with IC. Methods: Patients newly diagnosed with IC were requested to wear an activity monitor 1 week prior to and 1 week immediately after 3 months of SET. The primary outcome was the percentage of patients meeting the minimum recommendations of PA (American College of Sports Medicine [ACSM]/American Heart Association [AHA] recommendation for public health of >= 67 metabolic equivalents [METs]/min/day, in bouts of >= 10 min) at baseline and after 3 months of SET. Additionally, daily PA level (METs/min), duration of ambulatory activities, daily number of steps, pain free walking distance (PFWD), maximal walking distance (MWD), and Short Form Health Survey (SF-36) health surveys were compared before and after SET. Results: Data from 41 participants were available for analysis. A higher number of participants met the ACSM minimum recommendation for PA at the 3 month follow up (baseline: 43%; 3 months: 63%; p = .003). Despite significant increases in PFWD (baseline: 210 m; 3 months: 390 m; p = .001), MWD (baseline: 373 m; 3 months: 555 m; p = .002) and physical functioning score (SF-36) following SET, no increase in the mean daily PA level was found (395 +/- 220 vs. 411 +/- 228 METs/min; p = .43). Furthermore, the total number of steps and time spent in ambulatory activities did not change following SET. Conclusion: Three months of SET for IC leads to more patients meeting the ACSM/AHA public health minimum recommendations for PA. Assessment of PA could be incorporated as an outcome parameter in future research comparing different treatment modalities for peripheral arterial disease. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:184 / 191
页数:8
相关论文
共 50 条
  • [21] Wearable Activity Monitors in Home Based Exercise Therapy for Patients with Intermittent Claudication: A Systematic Review
    Chan, Calvin
    Sounderajah, Viknesh
    Normahani, Pasha
    Acharya, Amish
    Markar, Sheraz R.
    Darzi, Ara
    Bicknell, Colin
    Riga, Celia
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2021, 61 (04) : 676 - 687
  • [22] The Cost-effectiveness of Supervised Exercise for the Treatment of Intermittent Claudication
    Bermingham, S. L.
    Sparrow, K.
    Mullis, R.
    Fox, M.
    Shearman, C.
    Bradbury, A.
    Michaels, J.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2013, 46 (06) : 707 - 714
  • [23] Supervised exercise therapy in intermittent claudication: a systematic review of clinical impact and limitations
    Rodrigues, Egon
    Silva, Ivone
    INTERNATIONAL ANGIOLOGY, 2020, 39 (01) : 60 - 75
  • [24] Minimal correlation between physical exercise capacity and daily activity in patients with intermittent claudication
    Gommans, Lindy N. M.
    Hageman, David
    Jansen, Ingeborg
    de Gee, Robbie
    van Lummel, Rob C.
    Verhofstad, Nicole
    Scheltinga, Marc R. M.
    Teijink, Joep A. W.
    JOURNAL OF VASCULAR SURGERY, 2016, 63 (04) : 983 - 989
  • [25] Free-living Physical Activity as a Novel Outcome Measure in Patients with Intermittent Claudication
    Clarke, C. L.
    Holdsworth, R. J.
    Ryan, C. G.
    Granat, M. H.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2013, 45 (02) : 162 - 167
  • [26] The Effect of Arterial Disease Level on Outcomes of Supervised Exercise Therapy for Intermittent Claudication: A Prospective Cohort Study
    van den Houten, Marijn M. L.
    Jansen, Sandra
    van der Laan, Lijckle
    Vriens, Patrick W. H. E.
    Willigendael, Edith M.
    Koelemay, Mark J. W.
    Scheltinga, Marc R. M.
    Teijink, Joep A. W.
    ANNALS OF SURGERY, 2022, 275 (03) : 609 - 616
  • [27] Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
    Harwood, Amy E.
    Totty, Joshua P.
    Pymer, Sean
    Huang, Chao
    Hitchman, Louise
    Carradice, Daniel
    Wallace, Tom
    Smith, George Edward
    Chetter, Ian C.
    JOURNAL OF VASCULAR SURGERY, 2019, 69 (06) : 1899 - +
  • [28] Gender differences in daily ambulatory activity patterns in patients with intermittent claudication
    Gardner, Andrew W.
    Parker, Donald E.
    Montgomery, Polly S.
    Khurana, Aman
    Ritti-Dias, Raphael M.
    Blevins, Steve M.
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (05) : 1204 - 1210
  • [29] Integrative therapy in patients with intermittent claudication
    Minar, Erich
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2015, 44 (02) : 85 - 91
  • [30] The Role of Supervised Exercise Therapy in the Management of Symptomatic Peripheral Artery Disease with Intermittent Claudication
    Wu, Fang-Qin
    Deng, Qian-Wan
    Wang, Ji-Guang
    Li, Wen-Zhu
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2023, 25 (10) : 501 - 513